PlumX Metrics
Embed PlumX Metrics

Covid-19 and its impact on upper gastrointestinal (GI) cancer management

Cancers, ISSN: 2072-6694, Vol: 13, Issue: 3, Page: 1-11
2021
  • 7
    Citations
  • 0
    Usage
  • 55
    Captures
  • 0
    Mentions
  • 138
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    7
  • Captures
    55
  • Social Media
    138
    • Shares, Likes & Comments
      138
      • Facebook
        138

Review Description

Coronavirus disease 2019 (COVID-19), caused by the novel, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, has left dramatic footprints on human health and econ-omy. Cancer, whilst not an infective disease, is prevalent in epidemic proportions and cannot be pretermitted due to the impact of COVID-19. As we emanate from the second national lockdown in the UK with mixed feelings of hope and despair—due to vaccination and new COVID-19 variant, respectively—we reflect on the impact of the first wave on the provision on diagnosis and management of with upper gastrointestinal (UGI) cancers. This review provides a critical analysis of available literature on COVID-19 and its impact on cancer management in general and that of UGI cancers in particular.

Bibliographic Details

Fernando, Shalini; Veli, Mesel; Mohammadi, Borzoueh; Millar, Andrew; Khan, Khurum

MDPI AG

Medicine; Biochemistry, Genetics and Molecular Biology

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know